These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23152945)

  • 1. Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence.
    He L; Hristova K
    Sci Rep; 2012; 2():854. PubMed ID: 23152945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
    Saxon ML; Lee DC
    J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation.
    Cai G; Zhu L; Chen X; Sun K; Liu C; Sen GC; Stark GR; Qin J; Li X
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11531-11536. PubMed ID: 30352854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
    Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
    J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
    Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
    Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.
    Scheck RA; Lowder MA; Appelbaum JS; Schepartz A
    ACS Chem Biol; 2012 Aug; 7(8):1367-76. PubMed ID: 22667988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants for membrane binding of the EGFR juxtamembrane domain.
    Wu Z; Li L; Zhu L; Wang R; Dong Y; Zhang Y; Wang Y; Wang J; Zhu L
    FEBS Lett; 2024 Jun; 598(11):1402-1410. PubMed ID: 38589226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR oligomerization organizes kinase-active dimers into competent signalling platforms.
    Needham SR; Roberts SK; Arkhipov A; Mysore VP; Tynan CJ; Zanetti-Domingues LC; Kim ET; Losasso V; Korovesis D; Hirsch M; Rolfe DJ; Clarke DT; Winn MD; Lajevardipour A; Clayton AH; Pike LJ; Perani M; Parker PJ; Shan Y; Shaw DE; Martin-Fernandez ML
    Nat Commun; 2016 Oct; 7():13307. PubMed ID: 27796308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
    Li Y; Macdonald-Obermann J; Westfall C; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2012 Sep; 287(37):31116-25. PubMed ID: 22822073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
    Sanders JM; Wampole ME; Thakur ML; Wickstrom E
    PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition.
    Kozer N; Clayton AHA
    Eur Biophys J; 2020 Jan; 49(1):21-37. PubMed ID: 31740999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the EGFR juxtamembrane domain with PIP2-containing lipid bilayers: Insights from multiscale molecular dynamics simulations.
    Abd Halim KB; Koldsø H; Sansom MSP
    Biochim Biophys Acta; 2015 May; 1850(5):1017-1025. PubMed ID: 25219456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding.
    Macdonald-Obermann JL; Pike LJ
    Biochemistry; 2009 Mar; 48(11):2505-13. PubMed ID: 19196031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The juxtamembrane region of the EGF receptor functions as an activation domain.
    Red Brewer M; Choi SH; Alvarado D; Moravcevic K; Pozzi A; Lemmon MA; Carpenter G
    Mol Cell; 2009 Jun; 34(6):641-51. PubMed ID: 19560417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring higher-order EGFR oligomerisation and phosphorylation--a combined experimental and theoretical approach.
    Kozer N; Barua D; Orchard S; Nice EC; Burgess AW; Hlavacek WS; Clayton AH
    Mol Biosyst; 2013 Jul; 9(7):1849-63. PubMed ID: 23629589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.
    Thiel KW; Carpenter G
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19238-43. PubMed ID: 18042729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-Protein Interplay in Dimerization of Juxtamembrane Domains of Epidermal Growth Factor Receptor.
    Maeda R; Sato T; Okamoto K; Yanagawa M; Sako Y
    Biophys J; 2018 Feb; 114(4):893-903. PubMed ID: 29490249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB Receptors and Cancer.
    Wang Z
    Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between the juxtamembrane domain of the EGFR and calmodulin measured by surface plasmon resonance.
    Aifa S; Johansen K; Nilsson UK; Liedberg B; Lundström I; Svensson SP
    Cell Signal; 2002 Dec; 14(12):1005-13. PubMed ID: 12359306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.